Scribe Therapeutics

IPO

Rewriting medicine with molecular engineering

Scribe Therapeutics was founded in 2018, is headquartered in Alameda, United States, lists 51–200 employees, and has $145.0M in recorded funding across 3 rounds.

Employees
51–200
Founded
2018
Business Model
B2B
Total Funding
$145.0M
Last Round
$25.0M GrantJun 2026
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.

About

Scribe Therapeutics is a molecular engineering company developing best-in-class CRISPR-based genetic medicines, founded by Nobel Prize-winning CRISPR pioneer Jennifer Doudna and colleagues at UC Berkeley. The company engineers optimized in vivo CRISPR systems targeting cardiometabolic diseases, with partnerships with Eli Lilly and Sanofi and programs projected to enter the clinic in mid-2026.

Summary

Scribe Therapeutics is a Healthcare company based in Alameda, United States, founded in 2018. It lists 51–200 employees. It has raised $145.0M in total across 3 rounds, most recently a $25.0M Grant round in Jun 2026. Investors include Andreessen Horowitz, California Institute for Regenerative Medicine (CIRM) and Avoro Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOJul 2026
$128.7M

Sign up to see all 4 events

Funding: Series A through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Scribe Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/scribe-therapeutics"><img src="https://indexed.vc/api/badge/company/scribe-therapeutics" alt="Scribe Therapeutics on Indexed.vc" width="260" height="76" /></a>